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■ IN BRIEF Patients (n = 314) completed the Patient Health Questionnaire and
the Diabetes Distress Scale as part of standard care. Although most patients
(70.4%) had no symptoms of depression or diabetes-related distress, 23.9%
scored high on the distress questionnaire in at least one of its four domains.
Regular screening for distress related to the demands of living with diabetes
is crucial in identifying and preventing poor health outcomes associated with
diabetes-related distress.
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ore than 30 million people in the United States
have diabetes (1), a chronic
medical condition with unique selfmanagement challenges. For people
with diabetes, numerous daily self‐
care management activities are required to maintain healthy glycemic
control, including recommended fasting blood glucose and A1C levels (2).
The need for a healthy diet, regular
physical activity, self-monitoring of
blood glucose, and daily medications
has crucial implications for individuals’ health and is a constant reminder
of the chronicity of the disease.
The presence of diabetes doubles
the odds of co‐occurring depression
(3,4). Recent conservative estimates
indicate that comorbid depression
affects 8.7% of people with diabetes (5). The prevalence of subclinical
depression could be higher and has
been estimated at 18.9% (6). The
unadjusted rate of depression in people with diabetes may vary according
to their type of diabetes and medication regimen. Li et al. (7) reported
rates of 20.4% for those with type 1
diabetes, 24.0% for those with type 2
diabetes who are on insulin therapy,
and 17.3% for those with type 2 diabetes who are not using insulin.

Depression can have a significant
negative impact on functioning and
disease course for people with diabetes. More than a decade ago, a
large meta-analysis established that
poor glycemic management is linked
with depression (8). Depression
has been consistently significantly associated with a variety of
diabetes complications (e.g., macrovascular complications, retinopathy,
nephropathy, neuropathy, and sexual dysfunction [9]). A more recent
meta-analysis (10) identified a significant association between depression
and treatment nonadherence as a
possible pathway to worse clinical
outcomes for individuals with depression and diabetes.
Although depression is prevalent
among people with diabetes, diabetesrelated distress is even more common
and has potentially greater implications for the course of the disease
(11–13). Diabetes‐related distress
may be conceptualized as a person’s
concerns about self‐care, support,
emotional burden, and quality of
health care (11,14). Diabetes-related
distress is understandable given
that living with diabetes involves a
“complex, demanding, and often confusing set of self‐care directives” with
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diabetes-specific emotional distress
was related to A1C, but that A1C
was not associated with depression,
anxiety, or overall well-being (13).
Additionally, lower diabetes-related
distress is significantly related to self‐
efficacy and physician support (18).
The clinical picture of diabetesrelated distress and co-occurring
depression is murky (19). Diabetesrelated distress is distinct from
depression. Recent outcome studies have reported distress to be not
only more common than depression,
but also more salient and crucial to
address (12,13). Additionally, assessing depression has challenges in this
population because depressive symptoms can also mimic symptoms of
poorly managed diabetes (e.g., weight
loss, fatigue, sleep disturbances, and
difficulty concentrating) (3,20).
Universal screening for depression
in primary care and other medical

settings typically relies on the nineitem Patient Health Questionnaire
(PHQ‐9), developed to assist health
care providers in assessing depression
in adult patients (21). The PHQ‐9
includes questions about symptoms
of major depressive disorder over
the previous 2 weeks and is easily
administered and scored. It has been
validated for use in patients with diabetes (22). However, based on the
review mentioned above (9), screening
only for depression in the diabetes population may be inadequate.
Hermanns et al. (6) recommend using
a diabetes-related distress scale to better assess emotional challenges in this
population.
Assessing diabetes distress can
be accomplished with the 17‐
question Diabetes Distress Scale
(DDS‐17) (14). As shown in Table
1, this scale consists of four subscales for Emotional Burden (EB),

TABLE 1. The DDS-17
Emotional Burden (EB)
1.

Feeling that diabetes is taking up too much of my mental and physical energy every day

2.

Feeling angry, scared, and/or depressed when I think about living with diabetes

3.

Feeling that diabetes controls my life

4.

Feeling that I will end up with serious long-term complications, no matter what I do

5.

Feeling overwhelmed by the demands of living with diabetes

Physician-Related Distress (PD)
1.

Feeling that my doctor doesn’t know enough about diabetes and diabetes care

2.

Feeling that my doctor doesn’t give me clear enough directions on how to manage my diabetes

3.

Feeling that my doctor doesn’t take my concerns seriously enough

4.

Feeling that I don’t have a doctor who I can see regularly enough about my diabetes

Regimen-Related Distress (RD)
1.

Feeling that I am not testing my blood sugars frequently enough

2.

Feeling that I am often failing with my diabetes

3.

Not feeling confident in my day-to-day ability to manage diabetes

4.

Feeling that I am not sticking closely enough to a good meal plan

5.

Not feeling motivated to keep up my diabetes self-management

Interpersonal Distress (ID)
1.

Feeling that friends or family are not supportive enough of self-care efforts (e.g., planning activities that conflict
with my schedule, encouraging me to eat the “wrong” foods)

2.

Feeling that friends or family don’t appreciate how difficult living with diabetes can be

3.

Feeling that friends or family don’t give me the emotional support that I would like

Responses options are based on a 6-point Likert scale in which 1 = not a problem, 2 = a slight problem, 3 = a moderate
problem, 4 = a somewhat serious problem, 5 = a serious problem, and 6 = a very serious problem.
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which “patients may become frustrated, angry, overwhelmed, and/or
discouraged” (14).
Most patients with diabetes identified psychological/support challenges
as the primary barrier to optimal care
(15), and psychosocial barriers are
consistently related to poor diabetes
self‐management and low self‐efficacy
(16). The second Diabetes Attitudes,
Wishes and Needs (DAWN2) study
reported depression in ~13% of its
international 8,596-person sample,
and diabetes-related distress was
found in 44.6% of these patients (4).
Diabetes distress is associated
with poor glycemic management
and other negative health outcomes
(10,17). In cross-sectional and longitudinal analyses, Fisher et al. (12)
found that diabetes-related distress,
but not depression, was significantly
related to poorer A1C. Another crosssectional study also reported that
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Physician-Related Distress (PD),
Regimen-Related Distress (RD),
and Interpersonal Distress (ID) (14).
Higher DDS-17 scores were found
in women and younger patients
(18,23–25). More specifically, significantly higher RD and ID scores
were found in women (26) than for
men. However, despite the utility of
the DDS-17, it has not been widely
adopted in primary care or specialty
settings.
Objective

Administering both the PHQ-9 and
the DDS-17 could prove burdensome for patients and clinical staff
alike, particularly in busy primary
care clinics. Therefore, we aimed to
identify which measure proved more
sensitive in identifying the emotional concerns of patients in a diabetes
specialty clinic. We hypothesized that,
in a heterogeneous sample of patients
with diabetes, more patients would report clinical levels of diabetes-related
distress via the DDS-17 than significant levels of depression symptoms on
the PHQ-9.
Design

The Wilford Hall Ambulatory
Surgical Center institutional review
board approved this retrospective data
analysis. Data were collected at the Air
Force Diabetes Center of Excellence
(DCOE) in San Antonio, Tex., which
specializes in diabetes care for military
service members, retirees, and their
families. This clinic treats complex
cases of diabetes, including patients
with type 1 diabetes and patients
with multiple comorbidities. A chart
review of clinical encounters was conducted from visits that occurred from
June 2015 through August 2016.
Patients were routinely administered the PHQ-9 and the DDS-17 as
standard care. All patients included in
the study were adult patients with diabetes receiving their health care at this
clinic. As part of the initial patient
visit and as needed for reassessment,
patient responses to the PHQ-9
and the DDS-17 were recorded by a
licensed vocational nurse. After input,
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NoteWriter, a Microsoft Excel–based
clinical note-writing platform created
exclusively for use in the DCOE, calculated the total DDS-17 score and
scores for each subscale. These scores
were entered into patients’ electronic
health records.
Main Outcome Measures
Depression

The PHQ-9 was developed by
Kroenke et al. (21) and includes nine
questions about symptoms of major
depressive disorder experienced over
the previous 2 weeks. Responses indicate the frequency of experiencing
the given symptom using a scale in
which 0 = not at all, 1 = several days,
2 = more than half of the days, and
3 = nearly every day. A score ≥10 (of
a possible 27) is considered screening
positive for depression.
Diabetes-Related Distress

Fisher et al. (27) developed the DDS17, a 17-item Likert-scale questionnaire with responses that include the
degree to which a patient is bothered
by different symptoms (e.g., feeling
overwhelmed in life), as follows: 1 =
not a problem, 2 = a slight problem, 3 =
a moderate problem, 4 = a somewhat
serious problem, 5 = a serious problem, and 6 = a very serious problem.
There are three categories for DDS17 scores: <2.0 = little or no distress,
2.0–2.9 = moderate diabetes-related
distress, and ≥3 = high diabetes-related distress. As previously mentioned,
in addition to the total DDS-17 score,
there are four subscales: EB, PD, RD,
and ID. This analysis particularly focused on patients with overall scores
≥3, indicating high diabetes-related
distress.
Other Measures

In addition to PHQ-9 and DDS-17
scores, data collected included patient
demographics (sex, age, ethnicity/
race, rank, and military status), vital signs (e.g., blood pressure and
weight), and laboratory test results
(i.e., a comprehensive metabolic panel, including A1C). Data were stored

on military computers that are protected by password and firewall.
Data analyses were conducted
with SPSS version 22.0 (IBM Corp.,
Chicago, Ill.) statistical software.
Univariate analysis was conducted
to describe the patient population
and analyze patterns of diabetesrelated distress and depression in this
population, including overall and by
sex. In addition, bivariate correlations assisted in understanding the
strength of the relationship between
total and subscale DDS-17 scores and
PHQ-9 scores. In addition, crosstabulation was conducted to establish
how many patients were experiencing
diabetes-related distress, depression,
neither, or both.
Results

A total of 314 patients completed
both the DDS-17 and the PHQ-9 as
part of standard care from June 2015
through August 2016.
Demographics

Table 2 summarizes characteristics of
the sample. There were slightly more
men than women, and the average age
was ~57 years (range 19–87 years).
Mean age at diagnosis of diabetes was
older for men (42.84 years) than for
women (36.59 years); thus, duration
of diabetes was also longer for women.
About 42% of the sample were white,
and about one-third were Hispanic/
Latino.
The majority of military members
(retired and active duty) were enlisted
(i.e., non-officer; 86.8%) and male
(92.2%). Concerning military status, most men were retired, and most
women were dependent family members. About one-fourth of the patients
were diagnosed with type 1 diabetes,
and the majority of those were women
(58.4%), whereas the majority of
patients with type 2 diabetes were
male (54.6%). Mean BMI was 32.31
kg/m 2, and mean A1C was ~8.0%;
these characteristics were similar for
both sexes.
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TABLE 2. Sample Characteristics by Sex
Overall (n = 314)

Female (n = 153, 48.7%)

Male (n = 161, 51.3%)

Mean age, years

56.82

56.59

57.03

Mean age at diagnosis, years

39.81

36.59

42.84

Mean duration of diabetes, years

17.19

20.24

14.28

White, n (%)

131 (41.7)

64 (42.1)

67 (41.6)

African American, n (%)

69 (22.0)

25 (16.4)

44 (27.3)

Hispanic/Latino, n (%)

92 (29.4)

49 (32.2)

43 (26.7)

19 (6.1)

12 (7.9)

7 (4.3)

10 (3.2)

2 (1.3)

8 (5.0)

Ethnicity/race

Asian/Pacific Islander, n (%)
Military status
Retired, n (%)

143 (45.5)

10 (6.5)

133 (83.6)

Family member, n (%)

159 (50.6)

141 (92.2)

18 (11.3)
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Active duty, n (%)

Military rank (if military/retired)
Junior enlisted, n (%)

58 9 (18.5)

5 (3.3)

53 (32.9)

Senior enlisted, n (%)

74 (23.6)

4 (2.6)

70 (43.5)

Officer, n (%)

20 (6.4)

4 (2.6)

16 (9.9)

Type 1, n (%)

77 (24.5)

45 (29.4)

32 (19.9)

Type 2, n (%)

229 (72.9)

104 (68.0)

125 (77.6)

Type of diabetes

Other, n (%)

8 (2.5)

4 (2.6)

4 (2.5)

Mean BMI, kg/m2

32.31

31.67

32.91

Mean A1C, %

8.04

8.03

8.06

Note: due to rounding and missing data, percentages may not total 100%.

Relationship Between DDS-17
and PHQ-9 Scores

Of the 314 patients who completed
the DDS-17, 75 (23.9%) scored high
in at least one domain. High total
DDS-17 was found in 5.1% of the
population (Figure 1). The highest
diabetes-related distress subscale
scores were found in EB (15.6%) and
RD (14.6%). Women scored higher than men in each subscale of the
DDS-17 and were twice as likely as
men to score high in ID.
Thirty-seven patients (11.8%)
screened positive for depression using
the PHQ-9. However, about half
(5.7%) were not experiencing high
diabetes-related distress according to
the DDS-17. There was no difference
by sex in depression as measured by
the PHQ-9, with 18 males and 19
females meeting the threshold.
Bivariate correlations revealed
a significant association between
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PHQ-9 and total DDS-17 scores
(0.264, P <0.01); as well as among
DDS-17 subscales EB (0.291, P
<0.01), RD (0.205, P <0.01), and ID
(0.129, P <0.05). Further investigation of patients who screened positive
for depression (n = 37) revealed that
a higher percentage of these patients
scored high for total DDS-17 (18.9%),
EB (40.5%), RD (37.8%), and ID
(18.9%) compared to those who did
not screen positive for depression.
Furthermore, those who had a high
DDS-17 score in any domain were
nearly double the number of those
experiencing depressive symptoms
(Figure 2).
No significant relationship was
observed between A1C and screening positive for depression (0.043,
P = 0.45). However, total DDS-17
(0.314, P <0.01), EB (0.251, P <0.01),
and RD (0.344, P <0.01) were significantly associated with A1C.

Cross-tabulation analyses revealed
that most patients (70.4%) did not
screen positive for depression or have
high scores in any DDS-17 domain
(Figure 3). About one in five patients
(17.8%) had high DDS-17 scores in at
least one domain but did not screen
positive for depression. Of the 11.8%
of patients who screened positive for
depression, 19 patients (51.4%) also
had a high DDS-17 score in at least
one of the domains; however, 18
patients (48.6%) did not have a high
DDS-17 score in any domain. Thus,
almost one in four patients (23.9%)
had a high DDS-17 score in at least
one domain.
Discussion

Our study found that more patients
endorsed diabetes-related distress
than depression. Our hypothesis
was supported in that greater levels
of clinical distress were detected via
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■ FIGURE 1. Sex differences in elevated DDS-17 scores.

■ FIGURE 2. Comparison of depression and high scores in DDS-17 subscales.

■ FIGURE 3. Co-occurrence of depression and diabetes-related distress.

the DDS-17 than significant levels of
depression symptoms on the PHQ-9.
This is consistent with current literature, which reflects that, in patients
with diabetes, diabetes-related distress is common and distinct from
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depression (12,15). Distress in this
sample was highest in the subscales
EB and RD. Additionally, women
reported greater distress than men,
which is consistent with other studies
(18,23,24,26–28).

Our sample reported lower
diabetes-related distress than in the
DAWN2 study (4) or the BENCH-D
(Benchmarking Network for Clinical
and Humanistic Outcomes in
Diabetes) study (29). This may be due
to the setting, because the DCOE,
which is situated in a military health
system, exclusively treats patients with
complex diabetes. In addition, military beneficiaries do not have to pay
out-of-pocket costs for health care,
medication, or supplies.
The extremely low rate of reported
PD (1.3%) may suggest that patients
have greater confidence in this specialty clinic’s ability to manage
diabetes, which may also help to
explain the overall lower rates of distress. In addition, the DCOE employs
several proactive strategies that may
reduce diabetes-related distress (30).
For example, at new patient orientation, it is ensured that patients have
a primary care manager to address
other health issues as they arise.
It is important to highlight
that about half of our patients who
screened positive for depression did
not have diabetes-related distress. This
is consistent with findings from Fisher
et al. (31), who found that about onethird of people with diabetes who met
the criteria for depression did not have
high DDS-17 scores. In addition, the
3 Dimensions of Care for Diabetes
Study found that nearly one-third of
people with diabetes who screened
positive for depression did not have
high diabetes-related distress (32).
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diabetes-related distress also have
depressive symptoms (11).
Significance and Implications

Our findings suggest that it is important to screen patients with diabetes for
diabetes-related distress in addition to
depression as a standard of care, because patients with significant distress
will be missed if they are only screened
for depression. Additionally, because
of the distinct nature of diabetesrelated distress and depression, treatment implications must be considered. Medical providers, ideally an
interprofessional team, can use the
information from the DDS-17 to collaborate with patients on an evidencebased, patient-centered treatment plan
to effectively reduce distress (35). The
plan can be tailored to meet individual patient needs, improving both patients’ experience and health outcomes
(2). For example, if a particular patient has elevated scores in the DDS17 domains of ID and RD, it may
be clinically indicated to include key
significant others in diabetes self-management education classes to address
distress. Additionally, the DDS-17
allows the medical team to determine whether referrals are needed to
alleviate specific sources of diabetesrelated distress.
Limitations

Because this study was conducted in a
U.S. Air Force diabetes specialty clinic, its findings may not be transferable
to other military or civilian primary
care settings for several reasons. This
population represents those who require more complex diabetes care,
including all patients with type 1 diabetes, patients with multiple comorbidities, and patients using U-500
insulin therapy. Therefore, rates of
diabetes-related distress in this population may differ from the general
population of people with diabetes.
In addition, all of our patients are
part of the Department of Defense
health care system and therefore may
not be representative of the general
population.

However, this study represents a
robust sample of patients who concurrently responded to the DDS-17
and PHQ-9 questionnaires. Findings
are from a real-world clinical setting from a heterogeneous group of
patients with either type 1 or type
2 diabetes. This is the first study to
our knowledge to examine differences in diabetes-related distress and
depression in a clinical military health
system sample.
Future Directions

Future research should evaluate the
relationship between DDS-17 scores,
depression, and A1C in a clinical
setting, with attention to how interventions designed to reduce diabetesrelated distress may influence A1C.
In addition, exploring the context,
including individual, clinical, and
environmental predictors of elevated
scores on the DDS-17 and its subscales may enable providers to identify
those at risk for diabetes-related distress and proactively intervene. Such
intervention may include a menu of
strategies tailored to reduce distress
as measured by the four domains of
the DDS-17 that can be delivered by
providers in the clinical setting.
Diabetes distress is a normal
experience for many patients; it is
associated with daily management
of a chronic illness (and sometimes several chronic conditions).
Regularly assessing how patients are
coping with the demands of living
with diabetes and addressing those
stressors may improve outcomes
(36). Congruent with the American
Diabetes Association’s Standards
of Medical Care in Diabetes—2018
(2), regular psychosocial assessment
allows providers to intervene to promote better outcomes and quality of
life for patients. This study provides
additional support for use of the
DDS-17 as an essential psychosocial
assessment for people with diabetes.
Disclaimer
The views expressed in this article are those
of the authors and do not reflect the official
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Thus, screening for depression is
important; however, these findings
suggest that there is a subgroup of
people with diabetes who experience
depression that appears to be unrelated to diabetes. This unique group
of patients requires identification and
evidence-based interventions aimed at
general depression.
The PHQ-9 may overestimate
the prevalence of depression, especially in patients with chronic illness
(3,25). In fact, although the PHQ-9
was validated in patients with diabetes, depressive symptoms may be
confused with pathology related to
complications or symptoms of poorly
managed diabetes (22,25). In a recent
review of self-reported measures for
depression, 44–77% of people with
diabetes were found to have had
false-positive depression screening
results (33). Furthermore, Gonzalez
et al. (34) suggest that depression
screening tools rely solely on selfassessment of symptoms, while
ignoring the context in which these
symptoms occur. This may unduly
pathologize patients with diabetes,
while discounting the role chronic
illness plays in emotional symptoms.
Thus, it is important for providers to
not simply look at the total PHQ-9
score, but also inquire about the context for a score on a particular item
of concern.
If patients with diabetes are only
screened for depression, they may not
receive treatment for diabetes-related
distress, which is distinctly different
from depression. Although there were
significant correlations between the
PHQ-9 and the DDS-17, clinical cutoffs on each identified subgroups of
patients with distress alone or depression alone. In our study, twice as many
patients screened high in diabetesrelated distress in any domain than
patients who screened positive for
depression. In fact, nearly half of
patients who screened positive for
depression did not have high diabetesrelated distress in any domain. This is
consistent with literature, which suggests that only ~23% of patients with
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